RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ionis Pharmaceuticals Stock

Ionis Pharmaceuticals Equity 2025

Ionis Pharmaceuticals Equity

588.35 M USD

Ticker

IONS

ISIN

US4622221004

WKN

A2ACMZ

In 2025, Ionis Pharmaceuticals's equity was 588.35 M USD, a 52.15% increase from the 386.69 M USD equity in the previous year.

Ionis Pharmaceuticals Aktienanalyse

What does Ionis Pharmaceuticals do?

Ionis Pharmaceuticals is a biotechnology company specializing in the development and marketing of RNA-based therapeutics for the treatment of various diseases. The company was founded in 1989 and is headquartered in Carlsbad, California. Ionis Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Ionis Pharmaceuticals's Equity

Ionis Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ionis Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Ionis Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Ionis Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Ionis Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Ionis Pharmaceuticals stock

What is the equity of Ionis Pharmaceuticals this year?

Ionis Pharmaceuticals has equity of 588.35 M USD this year.

What was the equity of Ionis Pharmaceuticals compared to the previous year?

The equity of Ionis Pharmaceuticals has increased/decreased by 52.15% increased compared to the previous year.

What impact does a high equity have on investors of Ionis Pharmaceuticals?

A high equity is advantageous for investors of Ionis Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Ionis Pharmaceuticals?

A low equity can be a risk for investors of Ionis Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Ionis Pharmaceuticals affect the company?

An increase in equity of Ionis Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Ionis Pharmaceuticals affect the company?

A reduction in equity of Ionis Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Ionis Pharmaceuticals?

Some factors that can affect the equity of Ionis Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Ionis Pharmaceuticals so important for investors?

The equity of Ionis Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Ionis Pharmaceuticals take to change the equity?

To change equity, Ionis Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Ionis Pharmaceuticals pay?

Over the past 12 months, Ionis Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ionis Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Ionis Pharmaceuticals?

The current dividend yield of Ionis Pharmaceuticals is .

When does Ionis Pharmaceuticals pay dividends?

Ionis Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ionis Pharmaceuticals?

Ionis Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Ionis Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ionis Pharmaceuticals located?

Ionis Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ionis Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ionis Pharmaceuticals from 8/23/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/23/2025.

When did Ionis Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/23/2025.

What was the dividend of Ionis Pharmaceuticals in the year 2024?

In the year 2024, Ionis Pharmaceuticals distributed 0 USD as dividends.

In which currency does Ionis Pharmaceuticals pay out the dividend?

The dividends of Ionis Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Ionis Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Ionis Pharmaceuticals

Our stock analysis for Ionis Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ionis Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.